Bruker to acquire in-vitro diagnostics company ELITechGroup for €870m
Bruker Corporation (Nasdaq: BRKR) has solidified its position in the global life-science and diagnostics market through a definitive share purchase agreement to acquire ELITechGroup from ... Read More